HighTower Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $604K | Buy |
|
|||||
|
2025
Q1 | $557K | Sell |
|
|||||
|
2024
Q4 | $594K | Buy |
|
|||||
|
2024
Q3 | $518K | Buy |
|
|||||
|
2024
Q2 | $412K | Buy |
|
|||||
|
2024
Q1 | $337K | Hold |
|
|||||
|
2023
Q4 | $329K | Buy |
|
|||||
|
2023
Q3 | $275K | Buy |
|
|||||
|
2023
Q2 | $208K | Buy |
|
|||||
|
2023
Q1 | $203K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $256K | Buy |
|
|||||
|
2022
Q2 | $265K | Hold |
|
|||||
|
2022
Q1 | $333K | Sell |
|
|||||
|
2021
Q4 | $469K | Buy |
|
|||||
|
2021
Q3 | $419K | Buy |
|
|||||
|
2021
Q2 | $394K | Sell |
|
|||||
|
2021
Q1 | $458K | Sell |
|
|||||
|
2020
Q4 | $308K | Buy |
|
|||||
|
2020
Q3 | $290K | Buy |
|
|||||
|
2020
Q2 | $332K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $272K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $613K | Buy |
|